Candriam Equities L Oncology Impact C/ LU1864484214 /
| NAV2024-06-05 | Chg.+3.0200 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 244.6500EUR | +1.25% | reinvestment | Equity | Candriam ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 2024-06-07 | Public WebStation Live Factsheet | 2024 | English | - |
| 2024-06-03 | Prospectus | 2024 | English | 3,663.84 KB |
| 2024-06-03 | Prospectus | 2024 | German | 5,520.88 KB |
| 2024-03-01 | PRIIP Key Information Document | 2024 | German | 268.65 KB |
| 2023-12-31 | Account statment | 2023 | English | 5,416.37 KB |
| 2023-12-31 | Account statment | 2023 | German | 4,732.66 KB |
| 2023-06-30 | Semi-annual report | 2023 | English | 1,982.78 KB |
| 2023-06-30 | Semi-annual report | 2023 | German | 2,086.39 KB |
| 2022-07-02 | Key Investor Information | 2022 | German | 362.88 KB |
